Ansicht Scidel Pharma India Private Limited - Company Profile

It is a research & development private limited company based in Pune, Maharashtra, India, established in 2015.
2015 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Ansicht Scidel Pharma India Private Limited

Ansicht Scidel Pharma India Private Limited, a active private limited company, was established on 04 August 2015 in Pune, Maharashtra, India. Engaging in science research within the research & development sector, it holds CIN: U73100PN2015PTC156066. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Gaurav Anil Nahar (Director), Arati Ajinkya Inamdar (Director), Ajinkya Chintamani Inamdar (Director). Past directors included Anil Kantilal Nahar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S. No. 269/1, Plot 7, Cts. 4237, Kant Helix, Bhoir Colony, Opp. Tata Motors Limited,, Chinchwad, Pune, Maharashtra, 411033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100PN2015PTC156066

  • Registration Number

    156066

  • Incorporation Date

    04 August 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Ansicht Scidel Pharma India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ansicht Scidel Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ansicht Scidel Pharma India Private Limited?
Current Directors
Name Designation Appointment Date Status
Gaurav Anil Nahar Director 04 Aug 2015 Current
Arati Ajinkya Inamdar Director 04 Aug 2015 Current
Ajinkya Chintamani Inamdar Director 04 Aug 2015 Current
Darshan Sunil Nahar Director 04 Aug 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Jun 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ansicht Scidel Pharma India.

Ansicht Scidel Pharma India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Ansicht Scidel Pharma India revenue growth over time
Ansicht Scidel Pharma India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ansicht Scidel Pharma India?

In 2017, Ansicht Scidel Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ansicht Scidel Pharma India?

Unlock and access historical data on people associated with Ansicht Scidel Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ansicht Scidel Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ansicht Scidel Pharma India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ansicht Scidel Pharma India
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ansicht Scidel Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Ansicht Scidel Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.

  • Director Appointment

    Gaurav Anil Nahar was appointed as a Director was appointed as a Director on 04 Aug 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Arati Ajinkya Inamdar was appointed as a Director was appointed as a Director on 04 Aug 2015 & has been associated with this company since 10 years 7 months . was completed.

  • Director Appointment

    Progress on Ajinkya Chintamani Inamdar was appointed as a Director was appointed as a Director on 04 Aug 2015 & has been associated with this company since 10 years 7 months . was documented.

  • Director Appointment

    Darshan Sunil Nahar was appointed as a Director was appointed as a Director on 04 Aug 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ansicht Scidel Pharma India Private Limited?

The CIN of Ansicht Scidel Pharma India Private Limited is U73100PN2015PTC156066.

Where is Ansicht Scidel Pharma India Private Limited headquartered?

Ansicht Scidel Pharma India Private Limited is headquartered at S. No. 269/1, Plot 7, Cts. 4237, Kant Helix, Bhoir Colony, Opp. Tata Motors Limited,, Chinchwad, Pune, Maharashtra, 411033.

When was Ansicht Scidel Pharma India Private Limited incorporated?

Ansicht Scidel Pharma India Private Limited was incorporated on 04 August 2015.

Who are the current directors of Ansicht Scidel Pharma India Private Limited?

The current directors of Ansicht Scidel Pharma India Private Limited are

What is the primary industry of Ansicht Scidel Pharma India Private Limited?

The primary industry of Ansicht Scidel Pharma India Private Limited is Research & Development.

Is Ansicht Scidel Pharma India Private Limited a listed company?

Ansicht Scidel Pharma India Private Limited is unlisted.

What is the capital structure of Ansicht Scidel Pharma India Private Limited?

The authorized capital of Ansicht Scidel Pharma India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Ansicht Scidel Pharma India Private Limited?

The compliance status of Ansicht Scidel Pharma India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available